There was an association between TP53 (codon 72, arginine> proline), MDM2 (SNP309, T>G) polymorphisms and patient’s survival in bladder cancer after chemoradiotherapy (CRT) (67). The gene discussed is MDM2; the disease is urinary bladder carcinoma.